Latest Breaking News On - Barker ergun - Page 1 : comparemela.com

Towards a Future with More Cancer Survivors in Europe

Towards a Future with More Cancer Survivors in Europe
euractiv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from euractiv.com Daily Mail and Mail on Sunday newspapers.

Elcin barker ergunAntonella cardoneUniversity of cologneEuropean cancer organisationMenarini groupBarker ergunChief executive officerMember statesGenomic tumour testing Cancer patients europe

This Latvian Scientist Says His Startup Is Winning The AI Drug Discovery Race

Insilico Medicine, backed by blue-chip investors like Warburg Pincus and Qiming Venture Partners, has 17 preclinical drug candidates so far and earlier this month signed a $500 million licensing deal with Italy’s Menarini.

MoscowMoskvaRussiaChinaItalySingaporeLatviaHong kongQimingSichuanItalianChineseLatvianWarburg pincusAlex zhavoronkovMassimiliana landini aleotti

Insilico nabs $500M+ biobucks deal for preclinical cancer asset

Insilico nabs $500M+ biobucks deal for preclinical cancer asset
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

Menarini stemlineElcin barker ergunMenarini group stemline therapeuticsMenarini groupStemline therapeuticsInsilico medicineBarker ergun

EC approves Menarini Group's Orserdu for advanced or metastatic breast cancer

EC approves Menarini Group's Orserdu for advanced or metastatic breast cancer
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

Elcin barker ergunEuropean commissionMenarini group orserduMenarini groupStemline therapeuticsBarker ergun

EC approves Menarini's first of its kind breast cancer therapy

The European Commission has approved the Menarini Group’s Orsedu (elacestrant) as a monotherapy for the treatment of postmenopausal women and men with breast cancer.

MilanoLombardiaItalyElcin barker ergunGiuseppe curiglianoMenarini groupEuropean institute of oncologyEuropean commissionEuropean medicines agencyMedicinal productsHuman useBarker ergunEuropean instituteBio developmentsHe menarini groupBreast cancer